Skip to main content

Table 6 The preliminary categorization of high fall risk medicines (Category A) basing on their adverse drug effect (ADE) profiles in statutory summaries of product characteristics (SmPCs) and frequency of use in older patients who had experienced at least one documented fall in a geriatric care unit (n = 188). The medicines are organized according to the ATC Classification [38]

From: Inclusion of medication-related fall risk in fall risk assessment tool in geriatric care units

High fall risk (A)

ATC Code

ATC classification

Users of the medicines n (%)

Metoprolol

C07AB02

Beta blocking agents

49 (26.1)

Perindopril

C09AA04

ACE inhibitors

38 (20.2)

Tiapride

N05AL03

Antipsychotics

36 (19.1)

Quetiapine

N05AH04

Antipsychotics

24 (12.8)

Tramadol

N02AX02

Opioids

24 (12.8)

Citalopram

N06AB04

Antidepressants

23 (12.2)

Amlodipine

C08CA01

Calcium channel blockers

23 (12.2)

Melperone

N05AD03

Antipsychotics

23 (12.2)

Bromazepam

N05BA08

Anxiolytics

20 (10.6)

Ramipril

C09AA04

ACE inhibitors

18 (9.6)

Digoxin

C01AA05

Cardiac glycosides

18 (9.6)

Tramadol combination

N02AJ13

Opioids

16 (8.5)

Bisoprolol

C07AB07

Beta blocking agents

16 (8.5)

Zolpidem

N05CF02

Hypnotics and Sedatives

15 (8.0)

Donepezil

N06DA02

Anti-dementia drugs

14 (7.4)

Mirtazapine

N06AX11

Antidepressants

14 (7.4)

Amiodarone

C01BD01

Antiarrhythmics

14 (7.4)

Oxazepam

N05BA04

Anxiolytics

14 (7.4)

Tamsulosin

G04CA02

Urologicals

14 (7.4)

Memantine

N06DX01

Anti-dementia drugs

12 (6.4)

Diazepam

N05BA01

Anxiolytics

11 (5.9)

Gabapentin

N03AX12

Antiepileptics

11 (5.9)

Trazodone

N06AX05

Antidepressants

10 (5.3)

Isosorbide mononitrate

C01DA14

Vasodilatators

10 (5.3)

Clonazepam

N03AE01

Antiepileptics

10 (5.3)

Codein combination

N02AJ06

Opioids

9 (4.8)

Risperidone

N05AX08

Antipsychotics

8 (4.3)

Losartan

C09CA01

AT II receptor blockers

8 (4.3)

Sertraline

N06AB06

Antidepressants

7 (3.7)

Levodopa

N04BA01

Dopaminergic agents

7 (3.7)

Aminophylline

R03DA05

Drugs for obstructive airway diseases

7 (3.7)

Carvedilol

C07AG02

Beta blocking agents

7 (3.7)

Fentanyl

N02AB03

Opioids

6 (3.2)

Rosuvastatin

C10AA07

Lipid modifying agents

6 (3.2)

Betaxolol

C07AB05

Beta blocking agents

6 (3.2)

Haloperidol

N05AD01

Antipsychotics

6 (3.2)

Levomepromazine

N05AA02

Antipsychotics

6 (3.2)

Pregabalin

N03AX16

Antiepileptics

6 (3.2)

Nitrofurantoin

J01XE01

Antibacterials for systemic use

6 (3.2)

Urapidil

C02CA06

Antiadrenergic agents

5 (2.7)

Rilmenidine

C02AC06

Antiadrenergic agents

5 (2.7)

Nebivolol

C07AB12

Beta blocking agents

5 (2.7)

Escitalopram

N06AB10

Antidepressants

5 (2.7)

Telmisartan

C09CA07

AT II receptor blockers

5 (2.7)

Midazolam

N05CD08

Hypnotics and Sedatives

5 (2.7)

Alprazolam

N05BA12

Anxiolytics

5 (2.7)

Perindopril/Indapamide

C09BA04

ACE inhibitors combination

5 (2.7)

Verapamil

C08DA01

Calcium channel blockers

4 (2.1)

Amiloride/Hydrochlorthiazide

C03EA01

Diuretics

4 (2.1)

Rivastigmine

N06DA03

Anti-dementia drugs

4 (2.1)

Olanzapine

N05AH03

Antipsychotics

4 (2.1)

Dutasteride/Tamsulosin

G04CA52

Urologicals

4 (2.1)

Trimetazidine

C01EB15

Other cardiac preparations

4 (2.1)

Fosinopril

C09AA09

ACE inhibitors

3 (1.6)

Isosorbide dinitrate

C01DA08

Vasodilatators

3 (1.6)

Aceclofenac

M01AB16

Anti-inflammatory drugs

3 (1.6)

Captopril

C09AA01

ACE inhibitors

3 (1.6)

Baclofen

M03BX01

Muscle relaxants

3 (1.6)

Lansoprazole

A02BC03

Drug for peptic ulcer and reflux

3 (1.6)

Cefuroxime

J01DC02

Antibacterials for systemic use

3 (1.6)

Levetiracetam

N03AX14

Antiepileptics

2 (1.1)

Propafenone

C01BC03

Antiarrhythmics

2 (1.1)

Carbamazepine

N03AF01

Antiepileptics

2 (1.1)

Diclofenac

M01AB05

Anti-inflammatory drugs

2 (1.1)

Solifenacin/Tamsulosin

G04CA53

Urologicals

2 (1.1)

Oxycodone

N02AA05

Opioids

2 (1.1)

Trandolapril

C09AA10

ACE inhibitors

2 (1.1)

Levodopa/Carbidopa

N04BA02

Dopaminergic agents

2 (1.1)

Perindopril/Amlodipine/Indapamide

C09BX01

ACE inhibitors combination

2 (1.1)

Bicalutamide

L02BB03

Hormone antagonists

2 (1.1)

Glyceryl trinitrate

C01DA02

Vasodilatators

2 (1.1)

Fluoxetine

N06AB03

Antidepressants

1 (0.5)

Dosulepin

N06AA16

Antidepressants

1 (0.5)

Mianserin

N06AX03

Antidepressants

1 (0.5)

Candesartan

C09CA06

AT II receptor blockers

1 (0.5)

Venlafaxine

N06AX16

Antidepressants

1 (0.5)

Telmisartan/Hydrochlorothiazide

C09DA07

AT II receptor blockers combination

1 (0.5)

Tizanidine

M03BX02

Muscle relaxants

1 (0.5)

Lisinopril

C09AA03

ACE inhibitors

1 (0.5)

Famotidine

A02BA03

Drug for peptic ulcer and reflux

1 (0.5)

Quinapril/Hydrochlorothiazide

C09BA06

ACE inhibitors combination

1 (0.5)

Naftidrofuryl

C04AX21

Peripheral vasodilatators

1 (0.5)

Celiprolol

C07AB08

Beta blocking agents

1 (0.5)

Paroxetine

N06AB05

Antidepressants

1 (0.5)

Methyldopa

C02AB01

Antiadrenergic agents

1 (0.5)

Tianeptine

N06AX14

Antidepressants

1 (0.5)

Doxazosin

C02CA04

Antiadrenergic agents

1 (0.5)

Ticagrelor

B01AC24

Antithrombotic agents

1 (0.5)

Losartan/Hydrochlorothiazide

C09DA01

ACE inhibitors combination

1 (0.5)

Codeine

R05DA04

Cough suppressants

1 (0.5)

Acebutolol

C07AB04

Beta blocking agents

1 (0.5)

Mirabegron

G04BD12

Urologicals

1 (0.5)

Ibandronic acid

M05BA06

Drugs affecting bone

1 (0.5)

Levodopa/Benserazide

N04BA02

Dopaminergic agents

1 (0.5)

Selegiline

N04BD01

Dopaminergic agents

1 (0.5)

Moxonidine

C02AC05

Antiadrenergic agents

1 (0.5)

Irbesartan

C09CA04

ACE inhibitors

1 (0.5)

Perindopril/Amlodipine

C09BB04

ACE inhibitors combination

1 (0.5)

Cilazapril

C09AA08

ACE inhibitors

1 (0.5)

Fluphenazine

N05AB02

Antipsychotics

1 (0.5)

Ropinirole

N04BC04

Dopaminergic agents

1 (0.5)

Chlorprothixene

N05AF03

Antipsychotics

1 (0.5)